O. Dajani

发表

Clinicopathological factors associated with tumour‐specific mutation detection in plasma of patients with RAS‐mutated or BRAF‐mutated metastatic colorectal cancer

O. Lingjaerde, K. Spindler, H. Sorbye, 2021, International journal of cancer.

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy.

K. Spindler, O. Lingjærde, H. Sorbye, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.

K. Spindler, O. Lingjærde, H. Sorbye, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparing Two Classifications of Cancer Cachexia and Their Association with Survival in Patients with Unresected Pancreatic Cancer

M. Hjermstad, P. Iversen, A. Bye, 2015, Nutrition and cancer.

Ca2+-mediated activation of ERK in hepatocytes by norepinephrine and prostaglandin F2α: role of calmodulin and src kinases

L. S. Nilssen, D. Sandnes, T. Christoffersen, 2002, BMC Cell Biology.

Dual effects of glucagon and cyclic amp on dna synthesis in cultured rat hepatocytes: Stimulatory regulation in early G1 and inhibition shortly before the s phase entry

M. Refsnes, G. H. Thoresen, T. Christoffersen, 1990, Journal of cellular physiology.

The relationship between activation of phosphoinositide-specific phospholipase C and growth stimulation by Ca2+-mobilizing hormones in hepatocytes.

D. Sandnes, T. Christoffersen, O. Dajani, 1999, Pharmacology & toxicology.

Prostaglandins Enhance Epidermal Growth Factor-Induced DNA Synthesis in Hepatocytes by Stimulation of E Prostanoid 3 and F Prostanoid Receptors

D. Sandnes, T. Christoffersen, O. Dajani, 2007, Journal of Pharmacology and Experimental Therapeutics.

Prostaglandins Enhance EGF-induced DNA synthesis in Hepatocytes by Stimulation of EP3 and FP Receptors*

T. Christoffersen, O. Dajani, Kristin Meisdalen, 2007 .

Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: Role of alpha1‐ and beta‐adrenergic mechanisms

M. Refsnes, G. H. Thoresen, D. Sandnes, 1992, Journal of cellular physiology.

Sustained diacylglycerol accumulation resulting from prolonged G protein‐coupled receptor agonist‐induced phosphoinositide breakdown in hepatocytes

L. S. Nilssen, D. Sandnes, T. Christoffersen, 2005, Journal of cellular biochemistry.

Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2α additivity with the effect of norepinephrine, and synergism with epidermal growth factor

M. Refsnes, G. H. Thoresen, T. Christoffersen, 1994, Journal of cellular physiology.

Prostaglandin E2 upregulates EGF‐stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes

G. H. Thoresen, D. Sandnes, T. Christoffersen, 2008, Journal of cellular physiology.

Mechanisms of hepatocyte growth regulation by hormones and growth factors

M. Refsnes, G. H. Thoresen, D. Sandnes, 2000 .

Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells

J. Ødegård, D. Sandnes, T. Christoffersen, 2011, BMC Cancer.

A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients with Advanced Malignancies

P. Munster, S. Piha-Paul, A. Hollebecque, 2015, Clinical Cancer Research.

Dexamethasone inversely regulates DNA synthesis and phosphoenolpyruvate carboxykinase mRNA levels in cultured rat hepatocytes: interactions with insulin, glucagon, and transforming growth factor beta 1.

M. Refsnes, G. H. Thoresen, T. Christoffersen, 1995, Pharmacology & toxicology.

Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells

J. Ødegård, D. Sandnes, T. Christoffersen, 2012, Journal of Experimental & Clinical Cancer Research.

Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells

J. Ødegård, D. Sandnes, T. Christoffersen, 2012, Journal of experimental & clinical cancer research : CR.

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.

H. Sorbye, E. Kure, E. Skovlund, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidermal Growth Factor Behaves as a Partial Agonist in Hepatocytes: Effects on DNA Synthesis in Primary Culture and Competition with Transforming Growth Factor α

E. Taraldsrud, E. R. Moberg, G. H. Thoresen, 1996 .

Growth‐promoting effects of Ca2+‐mobilizing agents in hepatocytes: Lack of correlation between the acute activation of phosphoinositide‐specific phospholipase C and the stimulation of DNA synthesis by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2α

M. Refsnes, G. H. Thoresen, T. Christoffersen, 1996, Journal of cellular physiology.

On the mechanisms of the growth‐promoting effect of prostaglandins in hepatocytes: The relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide‐specific phospholipase C

M. Refsnes, G. H. Thoresen, T. Christoffersen, 1995, Journal of cellular physiology.

Growth Stimulation Mediated by G Protein Coupled Receptors in Hepatocytes: Synergism with Epidermal Growth Factor and Mechanisms of Signal Transduction

M. Refsnes, G. H. Thoresen, D. Sandnes, 1994 .

Healthcare professionals’ experiences and perspectives on using telehealth for home-based palliative care: a scoping review protocol (Preprint)

Heidi Holmen, Anette Winger, S. Steindal, 2021 .

Health Care Professionals’ Experiences and Perspectives on Using Telehealth for Home-Based Palliative Care: Protocol for a Scoping Review

Heidi Holmen, Anette Winger, S. Steindal, 2021, JMIR research protocols.

Quality of life as a prognostic factor for survival in hepatocellular carcinoma

T. Wilsgaard, H. Hagström, P. Stål, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway—Results from a Cluster Randomized Trial

M. Hjermstad, S. Kaasa, J. Hamfjord, 2021, Cancers.

Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours.

P. Munster, S. Piha-Paul, A. Hollebecque, 2015, European journal of cancer.

Antitumormidler rettet mot tyrosinkinaser

G. H. Thoresen, T. Christoffersen, T. Guren, 2005 .

PALLiON – PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care

M. Hjermstad, S. Kaasa, C. Brunelli, 2020, Trials.

Safety/efficacy of MK-8669 (ridaforolimus) plus MK-2206 (AKT inhibitor) in patients with advanced breast cancer with low RAS signature and PTEN deficient prostate cancer.

P. Munster, S. Piha-Paul, A. Hollebecque, 2014 .

Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells

J. Ødegård, D. Sandnes, T. Christoffersen, 2012, Journal of Experimental & Clinical Cancer Research.